What is the appropriate work‑up for parathyroid hormone‑independent hypercalcemia?

Work-up for PTH-Independent Hypercalcemia

Measure intact PTH first to confirm PTH-independent hypercalcemia (PTH <20 pg/mL), then immediately pursue malignancy evaluation as the most common cause, followed by systematic assessment for granulomatous disease, medications, and vitamin D-mediated mechanisms.

Initial Diagnostic Algorithm

Step 1: Confirm PTH-Independent Status

• Measure serum intact PTH - this is the single most important initial test 1
• PTH <20 pg/mL (depending on assay) confirms PTH-independent hypercalcemia 1
• Intact PTH assay is superior to mid-region PTH, especially when renal insufficiency is present 2

Step 2: Assess Severity and Clinical Context

Classify hypercalcemia severity to guide urgency 3:

• Mild: Calcium <12 mg/dL (3 mmol/L)
• Moderate: Calcium 12-14 mg/dL (3-3.5 mmol/L)
• Severe: Calcium >14 mg/dL (3.5 mmol/L)

Look for specific symptoms: fatigue, constipation, cognitive dysfunction (mild); polyuria, polydipsia, renal failure, nausea, vomiting, confusion, somnolence (moderate to severe) 3, 1

Step 3: Malignancy Work-up (First Priority)

Malignancy accounts for most inpatient PTH-independent hypercalcemia 4. Pursue this aggressively:

• PTHrP (PTH-related peptide) - elevated in humoral hypercalcemia of malignancy
• Imaging for occult malignancy:
  • Chest CT for lung cancer, lymphoma
  • Abdominal/pelvic CT or MRI for renal cell carcinoma, other solid tumors 5
  • Consider PET-CT if initial imaging unrevealing 6, 7
• Serum/urine protein electrophoresis with immunofixation for multiple myeloma
• Skeletal survey if multiple myeloma suspected
• Look for Leser-Trélat sign (sudden onset of multiple seborrheic keratoses suggesting internal malignancy) 5

The most common malignancies causing hypercalcemia are breast, lung, renal cancer, and multiple myeloma 3

Step 4: Vitamin D-Mediated Hypercalcemia

Measure 1,25-dihydroxyvitamin D (calcitriol) and 25-hydroxyvitamin D 6, 7:

If 1,25-dihydroxyvitamin D elevated:

• Granulomatous diseases (most common: sarcoidosis, also tuberculosis, fungal infections, silicone granulomas)
• Lymphomas (particularly Hodgkin's and non-Hodgkin's)
• Measure serum ACE (angiotensin-converting enzyme) - elevated in sarcoidosis 6, 7
• 18F-FDG PET-CT to identify granulomatous tissue (may show muscle, lymph node, or organ involvement) 6, 7
• Tissue biopsy of accessible lesions showing non-caseating granulomas confirms sarcoidosis 6, 7

If 25-hydroxyvitamin D elevated:

• Vitamin D intoxication from supplements

Step 5: Medication and Supplement Review

Discontinue any causative agents immediately 1, 8:

• Thiazide diuretics - common culprit 5
• Calcium supplements - assess intake including dietary sources (milk consumption) 5
• Vitamin D or vitamin A supplements 1
• Lithium
• Sodium-glucose cotransporter 2 inhibitors 1
• Immune checkpoint inhibitors 1
• Recent denosumab discontinuation (rebound hypercalcemia) 1

Step 6: Endocrinopathies

• Thyroid function tests (TSH, free T4) - hyperthyroidism causes increased bone turnover 9
• Anti-TSH receptor antibodies if hyperthyroidism present 9
• Consider adrenal insufficiency (rare cause)

Step 7: Additional Considerations

• Immobilization history - prolonged bed rest increases bone resorption 1
• Familial hypocalciuric hypercalcemia - check 24-hour urine calcium (low calcium-to-creatinine clearance ratio <0.01) 8
• Renal function - assess BUN and creatinine as renal insufficiency complicates interpretation and management 6
• Parathyroid carcinoma - rare but consider if history of prior parathyroidectomy with persistent hypercalcemia 3

Common Pitfalls to Avoid

1. Cognitive anchoring: Don't assume a single cause - multiple etiologies can coexist (e.g., parathyroid adenoma + renal cell carcinoma + thiazide use) 5

2. Renal insufficiency confounding: Use intact PTH assay rather than mid-region PTH when creatinine is elevated, as PTH fragments accumulate 2

3. Missing occult malignancy: Lymphadenopathy, splenomegaly, and constitutional symptoms can occur in both malignancy and sarcoidosis - tissue diagnosis is essential 6

4. Overlooking hereditary syndromes: Multiple tumors (vestibular schwannoma, parathyroid adenoma, RCC) suggest MEN2A, neurofibromatosis type 2, or von Hippel-Lindau disease - refer for genetic evaluation 5

5. Delayed granulomatous disease diagnosis: Sarcoidosis can present with isolated muscle involvement without pulmonary findings - PET-CT and muscle biopsy may be needed 7

Structured Diagnostic Sequence Summary

1. Intact PTH → confirms PTH-independent if <20 pg/mL
2. PTHrP + imaging → rule out malignancy first
3. 1,25-dihydroxyvitamin D + ACE → assess for granulomatous disease/lymphoma
4. Medication review → discontinue thiazides, supplements
5. Thyroid function → exclude hyperthyroidism
6. PET-CT + biopsy → if diagnosis remains unclear after above steps

This algorithmic approach prioritizes life-threatening causes (malignancy) while systematically excluding other PTH-independent etiologies to enable targeted treatment and improve morbidity and mortality outcomes 3, 1.